Skip to main content
Skip to main content
ASTH logo

Astrana Health, Inc. (ASTH)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Astrana Health, Inc. (ASTH) trades at $20.33 with AI Score 60/100 (Hold). Astrana Health, Inc. operates as a healthcare management company in the United States, focusing on value-based care. Market cap: 2B, Sector: Healthcare.

Last analyzed: Feb 9, 2026
Astrana Health, Inc. operates as a healthcare management company in the United States, focusing on value-based care. The company leverages its technology platform and integrated model to empower providers and improve patient outcomes.
60/100 AI Score Target $34.00 (+67.2%) MCap 2B Vol 432K

Astrana Health, Inc. (ASTH) Healthcare & Pipeline Overview

CEOBrandon K. Sim
Employees1900
HeadquartersAlhambra, CA, US
IPO Year2009

Astrana Health (ASTH) is a physician-centric, technology-powered healthcare management company driving value-based care through its integrated platform. With a focus on care coordination and a growing network, Astrana Health is positioned to capitalize on the shift towards preventative, patient-centered healthcare, despite its current low profit margin of 0.3%.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 9, 2026

Investment Thesis

Astrana Health presents a notable research candidate due to its focus on value-based care and technology-driven healthcare management. The company's integrated platform and physician-centric approach are well-aligned with the industry's shift towards preventative and coordinated care. While the current P/E ratio is high at 108.83 and the profit margin is low at 0.3%, the company's strategic positioning and growth opportunities could drive future profitability. Key catalysts include expanding its care network, leveraging its technology platform for greater efficiency, and capitalizing on the growing demand for value-based care models. The company's beta of 0.89 suggests lower volatility compared to the market, making it a potentially noteworthy option for risk-averse investors seeking exposure to the healthcare sector.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market capitalization of $1.06 billion, reflecting investor confidence in Astrana Health's growth potential.
  • Operates through three segments: Care Partners, Care Delivery, and Care Enablement, providing a comprehensive suite of healthcare services.
  • P/E ratio of 108.83, indicating a premium valuation based on current earnings.
  • Gross margin of 10.1%, highlighting opportunities for improvement in operational efficiency.
  • Beta of 0.89, suggesting lower volatility compared to the overall market.

Competitors & Peers

Strengths

  • Proprietary technology platform for population health management.
  • Integrated value-based care model.
  • Established physician network.
  • Focus on care coordination services.

Weaknesses

  • Low profit margin of 0.3%.
  • High P/E ratio of 108.83.
  • Reliance on insurance reimbursements.
  • Limited geographic diversification.

Catalysts

  • Expansion of the care network to new geographic areas.
  • Continued development and integration of the technology platform.
  • Increasing adoption of value-based care models by payers and providers.
  • Potential strategic acquisitions to expand service offerings.
  • Positive results from clinical trials or research studies demonstrating the effectiveness of the company's care model.

Risks

  • Changes in healthcare regulations, such as the Affordable Care Act, could negatively impact the company's business.
  • Increased competition from other healthcare providers could erode market share and profitability.
  • Pressure from payers to reduce reimbursement rates could squeeze margins.
  • Economic downturn could reduce patient access to healthcare and negatively impact revenue.
  • Cybersecurity breaches or data privacy violations could damage the company's reputation and result in financial losses.

Growth Opportunities

  • Expanding Care Network: Astrana Health has the opportunity to expand its network of primary care physicians, specialist physicians, and extenders. By increasing its network coverage, the company can reach a larger patient population and drive revenue growth. The market for physician network expansion is significant, with the potential to capture a larger share of the healthcare market. Timeline: Ongoing.
  • Leveraging Technology Platform: Astrana Health's proprietary population health management and healthcare delivery platform offers significant growth opportunities. By further developing and integrating its technology, the company can improve care coordination, enhance patient engagement, and drive operational efficiencies. The market for healthcare technology solutions is rapidly growing, driven by the need for improved data analytics and patient management. Timeline: Ongoing.
  • Capitalizing on Value-Based Care: The shift towards value-based care models presents a major growth opportunity for Astrana Health. By demonstrating improved patient outcomes and cost savings, the company can attract more patients, physician groups, and health plans. The market for value-based care is expanding as healthcare providers and payers seek to improve quality and reduce costs. Timeline: Ongoing.
  • Strategic Acquisitions: Astrana Health can pursue strategic acquisitions to expand its geographic reach, enhance its service offerings, and gain access to new technologies. The market for healthcare acquisitions is active, with numerous opportunities to acquire complementary businesses. Timeline: Ongoing.
  • Expanding Service Offerings: Astrana Health can expand its service offerings to include additional healthcare services, such as telehealth, remote patient monitoring, and chronic disease management. By offering a broader range of services, the company can attract more patients and generate additional revenue streams. The market for these services is growing rapidly, driven by the increasing demand for convenient and accessible healthcare. Timeline: Ongoing.

Opportunities

  • Expanding care network.
  • Capitalizing on the shift towards value-based care.
  • Strategic acquisitions.
  • Expanding service offerings.

Threats

  • Changes in healthcare regulations.
  • Increased competition from other healthcare providers.
  • Pressure from payers to reduce reimbursement rates.
  • Economic downturn affecting patient access to healthcare.

Competitive Advantages

  • Proprietary Technology Platform: Astrana Health's population health management and healthcare delivery platform provides a competitive advantage by enabling efficient care coordination and data-driven decision-making.
  • Integrated Value-Based Care Model: The company's integrated model aligns incentives between providers and payers, leading to improved patient outcomes and cost savings.
  • Established Physician Network: Astrana Health's network of primary care physicians, specialists, and hospitalists provides a strong foundation for growth and expansion.
  • Care Coordination Services: Astrana Health's care coordination services differentiate it from competitors and enhance patient engagement.

About ASTH

Astrana Health, Inc., formerly known as Apollo Medical Holdings, Inc., was incorporated in 1985 and rebranded in February 2024, signaling a renewed focus on its mission. Headquartered in Alhambra, California, Astrana Health operates as a physician-centric, technology-powered healthcare management company. The company's core business revolves around providing medical care services within the United States. Astrana Health operates through three key segments: Care Partners, Care Delivery, and Care Enablement. These segments work synergistically to deliver a comprehensive suite of healthcare services. Astrana Health leverages its proprietary population health management and healthcare delivery platform to operate an integrated, value-based healthcare model. This model empowers providers within its network to deliver enhanced care to their patients. The company offers care coordination services, extending its reach to patients, families, primary care physicians, specialists, acute care hospitals, alternative inpatient care sites, physician groups, and health plans. Astrana Health's physician network comprises primary care physicians, specialist physicians and extenders, and hospitalists. The company serves a diverse patient base, primarily those covered by private or public insurance, including Medicare, Medicaid, and health maintenance organization plans, as well as non-insured patients. Astrana Health's commitment to technology and value-based care positions it as a key player in the evolving healthcare landscape.

What They Do

  • Provides medical care services in the United States.
  • Operates through three segments: Care Partners, Care Delivery, and Care Enablement.
  • Leverages a proprietary population health management and healthcare delivery platform.
  • Operates an integrated, value-based healthcare model.
  • Offers care coordination services to patients, families, and healthcare providers.
  • Manages a physician network consisting of primary care physicians, specialists, and hospitalists.
  • Serves patients covered by private or public insurance, as well as non-insured patients.

Business Model

  • Generates revenue through providing medical care services to patients.
  • Receives payments from private and public insurance plans, including Medicare and Medicaid.
  • Contracts with health maintenance organizations (HMOs) to provide care to their members.
  • Offers care coordination services to healthcare providers and organizations.

Industry Context

Astrana Health operates within the medical care facilities industry, a segment experiencing growth driven by an aging population and increasing demand for healthcare services. The industry is undergoing a shift towards value-based care models, emphasizing preventative care and improved patient outcomes. Astrana Health's focus on technology and integrated care positions it favorably within this evolving landscape. Competitors include companies like Acadia Healthcare Company (ACHC), which operates behavioral healthcare facilities, and Addus HomeCare Corporation (AVAH), which provides home care services. The industry is characterized by increasing consolidation and a focus on efficiency and cost containment.

Key Customers

  • Patients covered by private insurance plans.
  • Patients covered by public insurance plans, such as Medicare and Medicaid.
  • Health maintenance organizations (HMOs).
  • Primary care physicians, specialist physicians, and hospitalists.
AI Confidence: 73% Updated: Feb 9, 2026

Financials

Chart & Info

Astrana Health, Inc. (ASTH) stock price: $20.33 (-0.58, -2.77%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ASTH.

Price Targets

Consensus target: $34.00

MoonshotScore

60/100

What does this score mean?

The MoonshotScore rates ASTH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Common Questions About ASTH (Healthcare)

What does Astrana Health, Inc. do?

Astrana Health, Inc. operates as a healthcare management company, providing medical care services in the United States. The company's core business revolves around its integrated, value-based healthcare model, which empowers providers to deliver enhanced care to their patients. Astrana Health leverages its proprietary population health management and healthcare delivery platform to offer care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, and health plans. The company generates revenue through providing medical care services to patients and receiving payments from private and public insurance plans.

Is ASTH stock worth researching?

ASTH stock presents a mixed investment profile. The company's focus on value-based care and technology-driven healthcare management aligns with industry trends, offering potential for long-term growth. However, the high P/E ratio of 108.83 and low profit margin of 0.3% raise concerns about valuation and profitability. Investors should carefully consider the company's growth opportunities, competitive landscape, and potential risks before making an investment decision. Monitoring the company's progress in expanding its care network, improving operational efficiency, and capitalizing on value-based care initiatives is crucial.

What are the main risks for ASTH?

Astrana Health faces several key risks, including changes in healthcare regulations, increased competition, and pressure from payers to reduce reimbursement rates. Changes in regulations, such as modifications to the Affordable Care Act, could significantly impact the company's business model and revenue streams. Increased competition from other healthcare providers could erode market share and profitability. Additionally, pressure from payers to reduce reimbursement rates could squeeze margins and negatively impact financial performance. Economic downturns could also reduce patient access to healthcare, affecting revenue.

What are the key factors to evaluate for ASTH?

Astrana Health, Inc. (ASTH) currently holds an AI score of 60/100, indicating moderate score. The stock trades at a P/E of 104.9x, above the S&P 500 average (~20-25x), suggesting high growth expectations. Analysts target $34.00 (+67% from $20.33). Key strength: Proprietary technology platform for population health management. Primary risk to monitor: Changes in healthcare regulations, such as the Affordable Care Act, could negatively impact the company's business. This is not financial advice.

How frequently does ASTH data refresh on this page?

ASTH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven ASTH's recent stock price performance?

Recent price movement in Astrana Health, Inc. (ASTH) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $34.00 implies 67% upside from here. Notable catalyst: Proprietary technology platform for population health management. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider ASTH overvalued or undervalued right now?

Determining whether Astrana Health, Inc. (ASTH) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 104.9. Analysts target $34.00 (+67% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying ASTH?

Before investing in Astrana Health, Inc. (ASTH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data and may be subject to change.
  • Investment decisions should be based on individual risk tolerance and financial circumstances.
Data Sources

Popular Stocks